Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 16 |
NetGPI | no | yes: 0, no: 16 |
Related structures:
AlphaFold database: E9AMY1
Term | Name | Level | Count |
---|---|---|---|
GO:0006508 | proteolysis | 4 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0016579 | protein deubiquitination | 6 | 2 |
GO:0019538 | protein metabolic process | 3 | 2 |
GO:0036211 | protein modification process | 4 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0043412 | macromolecule modification | 4 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0070646 | protein modification by small protein removal | 5 | 2 |
GO:0070647 | protein modification by small protein conjugation or removal | 5 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 17 |
GO:0008233 | peptidase activity | 3 | 17 |
GO:0016787 | hydrolase activity | 2 | 17 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 17 |
GO:0019783 | ubiquitin-like protein peptidase activity | 4 | 2 |
GO:0101005 | deubiquitinase activity | 5 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 209 | 213 | PF00656 | 0.545 |
CLV_NRD_NRD_1 | 156 | 158 | PF00675 | 0.616 |
CLV_PCSK_KEX2_1 | 156 | 158 | PF00082 | 0.564 |
CLV_PCSK_PC7_1 | 152 | 158 | PF00082 | 0.285 |
CLV_PCSK_SKI1_1 | 157 | 161 | PF00082 | 0.596 |
CLV_PCSK_SKI1_1 | 178 | 182 | PF00082 | 0.252 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.712 |
DEG_SPOP_SBC_1 | 21 | 25 | PF00917 | 0.455 |
DOC_CYCLIN_yCln2_LP_2 | 146 | 149 | PF00134 | 0.553 |
DOC_CYCLIN_yCln2_LP_2 | 184 | 187 | PF00134 | 0.448 |
DOC_MAPK_DCC_7 | 46 | 56 | PF00069 | 0.371 |
DOC_MAPK_MEF2A_6 | 178 | 185 | PF00069 | 0.475 |
DOC_MAPK_MEF2A_6 | 32 | 41 | PF00069 | 0.290 |
DOC_PP2B_LxvP_1 | 146 | 149 | PF13499 | 0.554 |
DOC_PP2B_LxvP_1 | 184 | 187 | PF13499 | 0.456 |
DOC_USP7_MATH_1 | 15 | 19 | PF00917 | 0.475 |
DOC_USP7_MATH_1 | 159 | 163 | PF00917 | 0.602 |
DOC_USP7_MATH_1 | 21 | 25 | PF00917 | 0.541 |
DOC_USP7_MATH_1 | 3 | 7 | PF00917 | 0.715 |
DOC_WW_Pin1_4 | 86 | 91 | PF00397 | 0.500 |
LIG_14-3-3_CanoR_1 | 156 | 164 | PF00244 | 0.439 |
LIG_AP2alpha_2 | 121 | 123 | PF02296 | 0.371 |
LIG_eIF4E_1 | 179 | 185 | PF01652 | 0.454 |
LIG_EVH1_2 | 90 | 94 | PF00568 | 0.486 |
LIG_FHA_2 | 23 | 29 | PF00498 | 0.423 |
LIG_LIR_Apic_2 | 47 | 53 | PF02991 | 0.371 |
LIG_MAD2 | 82 | 90 | PF02301 | 0.418 |
LIG_MYND_1 | 182 | 186 | PF01753 | 0.432 |
LIG_Pex14_2 | 138 | 142 | PF04695 | 0.481 |
LIG_Pex14_2 | 94 | 98 | PF04695 | 0.558 |
LIG_SH2_CRK | 128 | 132 | PF00017 | 0.490 |
LIG_SH2_NCK_1 | 27 | 31 | PF00017 | 0.436 |
LIG_SH2_SRC | 27 | 30 | PF00017 | 0.443 |
LIG_SH2_SRC | 70 | 73 | PF00017 | 0.572 |
LIG_SH2_STAP1 | 195 | 199 | PF00017 | 0.626 |
LIG_SH2_STAP1 | 27 | 31 | PF00017 | 0.436 |
LIG_SH2_STAP1 | 66 | 70 | PF00017 | 0.562 |
LIG_SH2_STAT5 | 179 | 182 | PF00017 | 0.246 |
LIG_SH2_STAT5 | 199 | 202 | PF00017 | 0.549 |
LIG_SH3_3 | 180 | 186 | PF00018 | 0.456 |
LIG_SH3_3 | 80 | 86 | PF00018 | 0.543 |
MOD_CK1_1 | 6 | 12 | PF00069 | 0.726 |
MOD_CK2_1 | 103 | 109 | PF00069 | 0.483 |
MOD_CK2_1 | 22 | 28 | PF00069 | 0.476 |
MOD_GlcNHglycan | 105 | 108 | PF01048 | 0.373 |
MOD_GlcNHglycan | 11 | 14 | PF01048 | 0.681 |
MOD_GlcNHglycan | 165 | 168 | PF01048 | 0.593 |
MOD_GlcNHglycan | 5 | 8 | PF01048 | 0.680 |
MOD_GlcNHglycan | 76 | 81 | PF01048 | 0.354 |
MOD_GSK3_1 | 11 | 18 | PF00069 | 0.555 |
MOD_GSK3_1 | 155 | 162 | PF00069 | 0.601 |
MOD_GSK3_1 | 3 | 10 | PF00069 | 0.645 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.678 |
MOD_NEK2_1 | 11 | 16 | PF00069 | 0.582 |
MOD_PIKK_1 | 100 | 106 | PF00454 | 0.538 |
MOD_PKA_2 | 155 | 161 | PF00069 | 0.439 |
MOD_Plk_4 | 195 | 201 | PF00069 | 0.553 |
MOD_Plk_4 | 46 | 52 | PF00069 | 0.553 |
MOD_ProDKin_1 | 86 | 92 | PF00069 | 0.500 |
TRG_DiLeu_BaEn_1 | 109 | 114 | PF01217 | 0.547 |
TRG_ENDOCYTIC_2 | 128 | 131 | PF00928 | 0.481 |
TRG_ENDOCYTIC_2 | 42 | 45 | PF00928 | 0.526 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HVE7 | Leptomonas seymouri | 52% | 89% |
A0A0N1PCI8 | Leptomonas seymouri | 64% | 97% |
A0A0S4JCD5 | Bodo saltans | 26% | 80% |
A0A1X0NHT4 | Trypanosomatidae | 41% | 75% |
A0A3Q8IAW2 | Leishmania donovani | 92% | 100% |
A0A3S7WQX3 | Leishmania donovani | 59% | 86% |
A0A422NZN2 | Trypanosoma rangeli | 40% | 89% |
A4H5V8 | Leishmania braziliensis | 74% | 100% |
A4HU52 | Leishmania infantum | 93% | 100% |
A4HU53 | Leishmania infantum | 59% | 86% |
D0A9N3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 92% |
E9AMY2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 57% | 86% |
Q4QHP4 | Leishmania major | 58% | 100% |
Q4QHP5 | Leishmania major | 90% | 100% |
V5BDG9 | Trypanosoma cruzi | 29% | 69% |